General Hospital of Thessaloniki Ippokrateio
Thessaloniki 54643
2 studies enrolling now · 11 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Generalized Pustular Psoriasis, Hidradenitis Suppurativa, Inflammation, Lung Diseases, Interstitial, Non-alcoholic Steatohepatitis, Obesity, Spinal Muscular Atrophy (SMA), Systemic Sclerosis, Type 2 Diabetes
Studies at this site
- A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
- A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) — Completed
- Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed
- Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa — Completed
- A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis — Completed
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
- A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD) — Completed